Richard Rosenquist
About
In The Last Decade
Richard Rosenquist
246 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Genetics 4.3k
- Pathology and Forensic Medicine 3.7k
- Immunology 2.5k
- Molecular Biology 2.0k
- Oncology 1.6k
Countries citing papers authored by Richard Rosenquist
This map shows the geographic impact of Richard Rosenquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Rosenquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Rosenquist more than expected).
Fields of papers citing papers by Richard Rosenquist
This network shows the impact of papers produced by Richard Rosenquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Rosenquist. The network helps show where Richard Rosenquist may publish in the future.
Co-authorship network of co-authors of Richard Rosenquist
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Rosenquist. A scholar is included among the top collaborators of Richard Rosenquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Rosenquist. Richard Rosenquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 8 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 11 | |
| 7 | 9 | |
| 8 | 13 | |
| 9 | 17 | |
| 10 | 10 | |
| 11 | 20 | |
| 12 | 53 | |
| 13 | 14 | |
| 14 | Ex Vivo Lymph Node Native Microenvironment Assay Shows Novel Antiproliferative Activity For Idelalisib And Ibrutinib On Cll Cells | 1 |
| 15 | Molecular Profiling In A Population Based Cohort Of Nordic Myelodysplastic Syndrome Patients | 1 |
| 16 | 33 | |
| 17 | The Perioperative Surgical Home Model | 21 |
| 18 | Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: A high-resolution genomic screening in newly diagnosed patients | 1 |
| 19 | 4 | |
| 20 | V(a)3-21 gene utilizing chronic lymphocytic leukemias display restricted V lambda 2-14 gene usage and homologous CDR3s. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.